1. Home
  2. HOFT vs KRRO Comparison

HOFT vs KRRO Comparison

Compare HOFT & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

N/A

Current Price

$12.43

Market Cap

144.6M

ML Signal

N/A

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

N/A

Current Price

$10.71

Market Cap

150.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HOFT
KRRO
Founded
1924
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.6M
150.0M
IPO Year
1999
2019

Fundamental Metrics

Financial Performance
Metric
HOFT
KRRO
Price
$12.43
$10.71
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$34.80
AVG Volume (30 Days)
22.0K
123.0K
Earning Date
04-16-2026
05-13-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$278,139,000.00
$6,392,000.00
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
181.46
52 Week Low
$8.62
$5.20
52 Week High
$15.99
$55.89

Technical Indicators

Market Signals
Indicator
HOFT
KRRO
Relative Strength Index (RSI) 43.93 41.32
Support Level $11.97 $9.51
Resistance Level $13.63 $14.42
Average True Range (ATR) 0.78 0.99
MACD -0.03 -0.09
Stochastic Oscillator 10.00 31.01

Price Performance

Historical Comparison
HOFT
KRRO

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: